期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Adenyl cyclase activator forskolin protects against Huntington's disease-like neurodegenerative disorders 被引量:3
1
作者 Sidharth Mehan Shaba Parveen Sanjeev Kalra 《Neural Regeneration Research》 SCIE CAS CSCD 2017年第2期290-300,共11页
Long term suppression of succinate dehydrogenase by selective inhibitor 3-nitropropionic acid has been used in rodents to model Huntington's disease where mitochondrial dysfunction and oxidative damages are primary p... Long term suppression of succinate dehydrogenase by selective inhibitor 3-nitropropionic acid has been used in rodents to model Huntington's disease where mitochondrial dysfunction and oxidative damages are primary pathological hallmarks for neuronal damage. Improvements in learning and memory abilities, recovery of energy levels, and reduction of excitotoxicity damage can be achieved through activation of Adenyl cyclase enzyme by a specific phytochemical forskolin. In this study, intraperitoneal administration of 10 mg/kg 3-nitropropionic acid for 15 days in rats notably reduced body weight, worsened motor cocordination(grip strength, beam crossing task, locomotor activity), resulted in learning and memory deficits, greatly increased acetylcholinesterase, lactate dehydrogenase, nitrite, and malondialdehyde levels, obviously decreased adenosine triphosphate, succinate dehydrogenase, superoxide dismutase, catalase, and reduced glutathione levels in the striatum, cortex and hippocampus. Intragastric administration of forskolin at 10, 20, 30 mg/kg dose-dependently reversed these behavioral, biochemical and pathological changes caused by 3-nitropropionic acid. These results suggest that forskolin exhibits neuroprotective effects on 3-nitropropionic acid-induced Huntington's disease-like neurodegeneration. 展开更多
关键词 nerve regeneration Huntington's disease mitochondria adenyl cyclase forskolin oxidative stress basal ganglia neural regeneration
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部